X4 Pharmaceuticals, Inc.XFORNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-88.96%
↑ 36% above average
Average (9y)
-139.31%
Historical baseline
Range
High:-32.87%
Low:-698.89%
CAGR
+11.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -88.96% | -37.4% |
| 2023 | -64.76% | +48.5% |
| 2022 | -125.71% | +10.4% |
| 2021 | -140.36% | -201.1% |
| 2020 | -46.62% | -17.9% |
| 2019 | -39.53% | +94.3% |
| 2018 | -698.89% | -672.6% |
| 2017 | -90.46% | -39.3% |
| 2016 | -64.96% | -97.6% |
| 2015 | -32.87% | - |